Picture of Zai Lab logo

ZLAB — Zai Lab News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapHigh Flyer

Brief: Zai Lab And Argenx Announce Approval Of Vyvgart® (Efgartigimod Alfa Injection) For Generalized Myasthenia Gravis In China

June 30 (Reuters) - Zai Lab Ltd  9688.HK :
    * ZAI LAB AND ARGENX ANNOUNCE APPROVAL OF VYVGART®
(EFGARTIGIMOD
ALFA INJECTION) FOR GENERALIZED MYASTHENIA GRAVIS IN CHINA
    * ZAI LAB LTD - TO SEEK NATIONAL REIMBURSEMENT DRUG LIST
INCLUSION
FOR VYVGART
    * ZAI LAB LTD - WILL NOW WORK WITH NATIONAL HEALTHCARE
SECURITY
ADMINISTRATION (NHSA) FOR NRDL INCLUSION TO ENABLE BROAD ACCESS
FOR PATIENTS

Source text for Eikon:  ID:nGNXbNKPlZ 
Further company coverage:  9688.HK 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Zai Lab

See all news